Health In Tech, Inc. cash flow to debt ratio of 2.24K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Health In Tech, Inc.'s free cash flow has decreased 104.40% from $1.28M last year to $-56.11K, signaling decreasing performance

Health In Tech, Inc.'s debt to equity ratio is 0.01, which means that the company's assets are healthy financed, signaling financial stability.

Health In Tech, Inc.'s debt has decreased relative to shareholder equity from 0.02 last year to 0.01 today, signaling strengthened financials

Health In Tech, Inc. has a net cash position, so leverage is healthy.

Health In Tech, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Health In Tech, Inc.'s profit margin has decreased (168.92%) in the last year from 3.44% to -2.37%, signaling decreasing performance

Health In Tech, Inc.'s short-term assets of $16.16M exceed its short-term liabilities of $5.16M

Health In Tech, Inc.'s return on assets of -2.79% is lower than the 5.00% threshold, indicating inefficient asset utilization

Health In Tech, Inc.'s return on equity of -4.47%, is lower than 15.00%, indicating bad performance

Health In Tech, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Health In Tech, Inc. has insufficient public price history to evaluate earnings stability.

Health In Tech, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Health In Tech, Inc. has negative free cash flow, indicating cash burn

Health In Tech, Inc.'s yearly earnings has increased 90.74% since last year from $670.48K to $1.28M, signaling increasing performance

Health In Tech, Inc.'s yearly revenue has increased 70.99% since last year from $19.49M to $33.33M, signaling increasing performance

ROIC -3.78% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Health In Tech, Inc.'s 3-year revenue CAGR of 79.42% is positive, indicating growing revenue over the past 3 years

Health In Tech, Inc. has insufficient public price history to evaluate revenue consistency.

Health In Tech, Inc. has insufficient public price history to evaluate ROE consistency.

Health In Tech, Inc. has insufficient data to evaluate this check.

Health In Tech, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Health In Tech, Inc. is overvalued relative to its fair value price of 0.48 based on EBITDA multiple model

Health In Tech, Inc. has an EV/EBITDA ratio of 20.50x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings

Health In Tech, Inc. has insufficient data to evaluate this check.

Health In Tech, Inc. has insufficient diluted EPS history to calculate the PEG ratio.

Health In Tech, Inc. has a price-to-book ratio of 2.97x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Health In Tech, Inc. has a price-to-sales ratio of 1.88x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue